Trial
NCT05109975
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Debiopharm International SA
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
Debio 0123
Why stopped
This trial was concluded for strategic reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23